| Literature DB >> 33390853 |
Wenqian Zhou1,2, He Cai1, Jia Li2,3, He Xu4, Xiang Wang1,2, Hongbo Men1,2, Yang Zheng1, Lu Cai2,5.
Abstract
Mediator complex subunit 13 (MED13, previously known as THRAP1 and TRAP240) is a subunit of the cyclin-dependent kinase 8 (CDK8) kinase module in the eukaryotic mediator complex. MED13 has been known to play critical roles in cell cycle, development, and growth. The purpose of this review is to comprehensively discuss its newly identified potential roles in myocardial energy metabolism and non-metabolic cardiovascular diseases. Evidence indicates that cardiac MED13 mainly participates in the regulation of nuclear receptor signaling, which drives the transcription of genes involved in modulating cardiac and systemic energy homeostasis. MED13 is also associated with several pathological conditions, such as metabolic syndrome and thyroid disease-associated heart failure. Therefore, MED13 constitutes a potential therapeutic target for the regulation of metabolic disorders and other cardiovascular diseases. © The author(s).Entities:
Keywords: MED13; cardiovascular diseases; energy metabolism
Mesh:
Substances:
Year: 2021 PMID: 33390853 PMCID: PMC7757031 DOI: 10.7150/ijbs.52290
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580